INS and metabolic dysfunction-associated steatotic liver disease: Lipotoxicity impairs insulin signaling, induces oxidative damage, and promotes inflammation and fibrosis [22], which is thought to be associated with the progression from simple steatosis to NASH, liver fibrosis and hepatocellular carcinoma in NAFLD patients.